Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05703750
What this trial is testing

Impact of Clinical Evident Portal Hypertension on HCC With TACE (CHANCE-CHESS 2301)

Who this might be right for
Hepatocellular CarcinomaPortal Hypertension
Zhongda Hospital 228
Testing effectiveness (Phase 2)UnknownNCT04233840
What this trial is testing

P1101 and Anti-PD1 for After Curative Surgery of Hepatitis B-related Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 72
Testing effectiveness (Phase 2)Looking for participantsNCT07246668
What this trial is testing

A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver NeoplasmsCarcinoma+1 more
Yonsei University 52
Early research (Phase 1)UnknownNCT03971747
What this trial is testing

AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai AbelZeta Ltd. 9
Not applicableActive Not RecruitingNCT06312826
What this trial is testing

Abbreviated MRI Using Gadoxetic Acid Versus Ultrasonography for Surveillance of Early-stage HCC in Patients at High Risk

Who this might be right for
Liver CirrhosisHepatocellular Carcinoma
Asan Medical Center 806
Not applicableNot Yet RecruitingNCT06749678
What this trial is testing

Effect of Prehabilitation During the Conversion Therapy on Postoperative Outcomes in Unresectable Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)Prehabilitation
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 84
Not applicableUnknownNCT00687778
What this trial is testing

11C-Acetate PET/CT Non-FDG-Avid Tumors

Who this might be right for
Soft Tissue SarcomasThyroid CancerLung Cancer+7 more
Tel-Aviv Sourasky Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT00004108
What this trial is testing

DX-8951f in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Daiichi Sankyo
Not applicableStudy completedNCT03356535
What this trial is testing

Metabolic Signature of Healthy Lifestyle and HCC

Who this might be right for
Hepatocellular Carcinoma
International Agency for Research on Cancer 294
Testing effectiveness (Phase 2)Looking for participantsNCT06698250
What this trial is testing

Zanzalintinib (XL-092) Plus Durvalumab and Tremelimumab in Unresectable Hepatocellular Carcinoma (ZENOBIA)

Who this might be right for
Hepatocellular Carcinoma
Anwaar Saeed 40
Testing effectiveness (Phase 2)Looking for participantsNCT06478719
What this trial is testing

To Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization

Who this might be right for
Hepatocellular Carcinoma
Febico Biomedical Corp. 120
Testing effectiveness (Phase 2)Study completedNCT05162352
What this trial is testing

Donafenib Plus Sintilimab for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University 30
Not applicableLooking for participantsNCT07295340
What this trial is testing

Diagnostic Accuracy of Folate-Targeted NIR-II Carbon Dots for Ex Vivo HCC Detection

Who this might be right for
Liver Cancer
West China Hospital 20
Testing effectiveness (Phase 2)Study completedNCT04997850
What this trial is testing

The Safety and Efficacy of Transarterial Chemoembolization (TACE) + Lenvatinib + Programmed Cell Death Protein 1 (PD-1) Antibody of Advanced Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectableTransarterial ChemoembolizationTyrosine Kinase Inhibitor+1 more
Xinrui Zhu，MD 142
Testing effectiveness (Phase 2)UnknownNCT04069949
What this trial is testing

Sorafenib Plus Toripalimab for Unresectable HCC With Portal Vein Tumor Thrombus

Who this might be right for
Unresectable Hepatocellular CancerPortal Vein Tumor Thrombus
Sichuan University 39
Not applicableWithdrawnNCT00746655
What this trial is testing

SBRT + TACE for Primary Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University of Pittsburgh
Testing effectiveness (Phase 2)Study completedNCT00875615
What this trial is testing

Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Liver Cancer
University of Miami 11
Not applicableEnded earlyNCT02649868
What this trial is testing

LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic Tumors

Who this might be right for
Hepatic CancerLiver NeoplasmsHepatocellular Cancer+1 more
National Institutes of Health Clinical Center (CC) 19
Early research (Phase 1)Active Not RecruitingNCT02817633
What this trial is testing

TSR-022 in Participants With Advanced Solid Tumors (AMBER)

Who this might be right for
Neoplasms
Tesaro, Inc. 463
Testing effectiveness (Phase 2)WithdrawnNCT02946138
What this trial is testing

Phase II Trial of Carbon-ion Radiotherapy Combined With GM-CSF for the Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Proton and Heavy Ion Center
Next Page